Home » Clinical Trials » Search Clinical Trials
Parent Therapeutic Areas: Oncology | Pediatrics/Neonatology | Neurology

Neuroblastoma

California

Duarte : City of Hope

COG ANBL00B1: Neuroblastoma Biology Studies

Los Angeles : Children's Hospital Los Angeles

A medical study for children with relapsed or refractory high-risk Neuroblastoma.

San Francisco : University of California, San Francisco

A medical study for children with relapsed or refractory high-risk Neuroblastoma.

Illinois

Chicago : University of Chicago Comer Children's Hospital

A medical study for children with relapsed or refractory high-risk Neuroblastoma.

Michigan

Ann Arbor : C. S. Mott Children's Hospital, University of Michigan

A medical study for children with relapsed or refractory high-risk Neuroblastoma.

Ohio

Cincinnati : Cincinnati Children's Hospital Medical Center/Cincinnati Children's Research Foundation

(ANBL0621) A Phase II Study of ABT-751 in Children with Relapsed or Refractory Neuroblastoma

Cincinnati : Cincinnati Children's Hospital Medical Center/Cincinnati Children's Research Foundation

¹³¹I-Metaiodobenzylguanidine (MIBG) with Intensive Chemotherapy and Autologous Stem Cell Rescue for High-Risk Neuroblastoma

Cincinnati : Cincinnati Children's Hospital Medical Center/Cincinnati Children's Research Foundation

¹³¹I-MIBG Expanded Access: An Open Label, Expanded Access Protocol Using ¹³¹I-Metaiodobenzylguanidine (¹³¹I-MIBG) Therapy in Patients With Refractory Neuroblastoma

Cincinnati : Cincinnati Children's Hospital Med. Center

A medical study for children with relapsed or refractory high-risk Neuroblastoma.

Cincinnati : Cincinnati Children's Hospital Medical Center/Cincinnati Children's Research Foundation

A Phase I Study of CEP-701 in Patients with Refractory Neuroblastoma

Cincinnati : Cincinnati Children's Hospital Medical Center/Cincinnati Children's Research Foundation

A Phase I Study Of Zoledronic Acid (Zometa) with Cyclophosphamide in Children with Recurrent or Refractory Neuroblastoma and Cortical Bone Involvement

Cincinnati : Cincinnati Children's Hospital Medical Center/Cincinnati Children's Research Foundation

Perinatal Neuroblastoma: Expectant Observation (Children's Oncology Group Pilot Study)

Cincinnati : Cincinnati Children's Hospital Medical Center/Cincinnati Children's Research Foundation

Phase I Study of Fenretinide (4-HPR, NSC 374551) Lym-X-Sorb™ (LXS) Oral Powder In Patients with Recurrent or Resistant Neuroblastoma IND# 68,254

Pennsylvania

Philadelphia : Children's Hospital

A medical study for children with relapsed or refractory high-risk Neuroblastoma.

Texas

Houston : Texas Children's Hospital, Baylor College of Medicine

A medical study for children with relapsed or refractory high-risk Neuroblastoma.

Houston : S. R. Burzynski Clinic

Phase II Study Of Antineoplastons A10 And AS2-1 In Patients With Neuroblastoma

Wisconsin

Madison : University of Wisconsin Medical Center

A medical study for children with relapsed or refractory high-risk Neuroblastoma.